Unlock instant, AI-driven research and patent intelligence for your innovation.
Pyrazine compounds and their compositions and uses
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of compound, the technology of composition, be used in pyrazine compound and its field as medicine
Active Publication Date: 2016-08-24
SUNSHINE LAKE PHARM CO LTD
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
According to literature reports, other anti-influenza virus drugs have good inhibitory effects on viruses and antiviral application prospects, but further demonstration is often needed
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0160] Example 1: 6-fluoro-3-((2-(2-hydroxybenzylamino)ethyl)amino)pyrazine-2-carboxamide
[0163] 2-Hydroxybenzoic acid (10g, 72mmol, 1eq.) was dissolved in EtOH (31.5mL), concentrated sulfuric acid (0.5mL, 9.39mmol) was added dropwise at 0°C, and the reaction solution was heated to 85°C for 16h. After the reaction, the reaction solution was concentrated, the residue was diluted with 20 mL of water, extracted with dichloromethane (20 mL x 2), dried over anhydroussodiumsulfate, and concentrated under reduced pressure to obtain the title compound (5.77 g, 48%) as a colorless oil .
[0165] Step 2: Synthesis of N-(2-aminoethyl)-2-hydroxybenzamide
[0166] A mixture of ethyl 2-hydroxybenzoate (3g, 18.05mmol, 1eq.) and ethylenediamine (1.21mL, 18.1mmol, 1eq.) was reacted and stirred at 110°C for 15h. After the reaction, the reaction solution was concentrated under re...
Embodiment 2
[0177] Example 2: 6-fluoro-3-((4-hydroxybenzyl)amino)pyrazine-2-carboxamide
[0178]
[0179]Step 1: Synthesis of 6-fluoro-3-((4-hydroxybenzyl)amino)pyrazine-2-carbonitrile
[0180] Dissolve 4-(aminomethyl)phenol (87mg, 0.71mmol, 1eq.) in anhydrous THF (8mL), then add 3,6-difluoropyrazine-2-carbonitrile (100mg, 0.71mmol, 1eq .), the reaction mixture was stirred at room temperature for 3 h, then concentrated under reduced pressure, and the residue was purified by silica gelcolumn chromatography (eluent: PE / EtOAc (V / V)=3 / 1) to obtain the title compound (66mg, 38 %).
[0182] Step 2: Synthesis of 6-fluoro-3-((4-hydroxybenzyl)amino)pyrazine-2-carboxamide
[0183] 6-Fluoro-3-((4-hydroxybenzyl)amino)pyrazine-2-carbonitrile (60mg, 0.25mmol, 1eq.) was dissolved in DMSO (2mL), and K 2 CO 3 (7mg, 0.05mmol, 0.2eq.) and H 2 o 2 (111mg, 0.98mmol, 4eq.), the reaction solution was stirred at room temperature for 2.5h. After the reactio...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a pyrazine compound and application thereof as a medicine, in particular to application thereof to preparation of medicines for preventing and treating various influenza viruses. Particularly, the invention relates to a compound shown in the general formula I and a stereoisomer, a geometrical isomer, a tautomer, a nitrogenoxide, a hydrate, a solvate, a metabolite, pharmaceutically acceptable salt or a prodrug thereof, and all variables are defined in the description. The invention also relates to a compound shown in the general formula I and application of a stereoisomer, a geometrical isomer, a tautomer, a nitrogenoxide, a hydrate, a solvate, a metabolite, pharmaceutically acceptable salt or a prodrug as medicines, particular to application thereof as medicines for preventing and treating influenza viruses.
Description
technical field [0001] The invention relates to a pyrazine compound and its use as medicine, and the compound of the invention is suitable for the use of preparing antiviral medicine. The present invention also relates to pharmaceutical compositions containing these compounds, and to the use of said compounds, alone or in combination with other agents, for the prevention and treatment of various viruses, especially for the prevention and treatment of influenza viruses. Background technique [0002] Influenza (influenza, referred to as influenza) is an acute respiratory infection caused by influenza virus, and it is also a highly contagious and fast-spreading disease. It is mainly spread through droplets in the air, person-to-person contact or contact with contaminated items. Typical clinical symptoms are: sudden onset of high fever, general pain, significant fatigue and mild respiratory symptoms. Generally, autumn and winter are the high-incidence period, and the complicat...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.